I didn’t remove any tweets this time. 4 bags draining
I didn’t remove any tweets this time. 4 bags draining into my arm and I’m probably 3/4 sleeping. From a stock perspective- a CEO doesn’t judge investors. Not in a way that matters. Investors judge CEOs. I empathize with Joe’s frustration as he tries to do the right things, as people can badger with comments that aren’t fair. Still his posts harm more than anything.
He cares as opposed to management of the past. His deals are hard to judge as the whole world came to a shutdown while Generex, from a precarious position, took financial risk attempting to move new assets around to form a new type of healthcare company. That’s stalled but not from mismanagement. Even as that pandemic induced hardship handcuffs the company, Joe continues trying to position the company to succeed by the new deals that have been announced. And that’s while the SEC partners with the pandemic in slowing down GNBT’s corporate plans. That must be infuriating for him, as he is thwarted from raising capital via S1s to achieve goals.
I’m offering a perspective and not an excuse. I’m also half baked on morphine so I don’t even know what I typed. I just know that as much as I appreciate the commitment and passion, I get concerned because investors can lose faith for variety of reasons. Joe would serve his own interests and that of the company’s by not posting on any message boards. Joe should just focus on the tasks at hand and know many of us support and appreciate him. Obviously, we expect results just as much as he does from his team.
Keep at it Joe, and great news today. I’m hoping for a domino effect at some point. One deal leads to another per say. Well, I have to hit the button for the dreadful Nurse Ratchet to stop this thing from beeping incessantly.
5
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Riding the Kaolin Wave: Industrial Market Expansion You can't miss the sound of kaolin clinking in as it rides the tide of industrial demand. Reports from MarketsandMarkets™ have kaolin's party rocking all the way to a hefty $8.89 billion by 2031, up from $6.19 billion in 2026. With a sensible 7.5% compound annual growth rate (CAGR), this clay’s is aiming for the...
Continue Reading
Neera Tanden Sets the Stage for 2027 When it comes to politics, everyone’s got their two cents, but Neera Tanden’s unpacking a whole piggy bank of progressive dreams. Set against the backdrop of a freshly reshuffled Congress post-midterms, she’s poised to dish out her roadmap for the future at the National Press Club on November 9. A Gathering of Minds This ain't...
Continue Reading
Clinical Stage Wonders and Bold Claims Here's the lowdown on the latest tale from Verismo Therapeutics, a name that's trying real hard to distinguish itself in the CAR T therapy arena. Grab a coffee, pal, and let's wade through what's cooking at their camp with the SynKIR™-110. Breaking Down the Science Jargon For you folks not knee-deep in immunotherapy, let me spell...
Continue Reading
Diving into the Vegas Real Estate Scene Alright, folks, let's roll up our sleeves and talk about something that's got my attention—Bascom Group's recent $30.8 million refinance of the Gateway Villas Apartments in Las Vegas. This ain't just another vanilla transaction in the back pages of some real estate journal. It's a play that screams strategy, especially in a world...
Continue Reading
Stellar Snacks' audacious venture into olive oil-based pretzels Ever thought pretzels would stir up a storm? Well, Stellar Snacks sure did. They're celebrating a blockbuster year by rolling out a brand-new line of olive oil-baked pretzel braids across Sprouts Farmers Market nationwide. This isn't just any rollout. It's a carefully crafted endeavor tailored to redefine how...
Continue Reading
Deadline Looms Large for AST SpaceMobile Investors Hot topic off the wire, folks: AST SpaceMobile's in hot water with a securities fraud class action lawsuit breathing down its neck. You got till November 13 to file for lead plaintiff status. If you picked up shares of NASDAQ:ASTS during the period from March 4, 2025, to July 15, 2026, now might just be the time to sit up...
Continue Reading
Shaping the Future with AI Integration In the whirlwind of innovation, there's always the ones braving the frontier, pushing the very boundaries of what we deem possible. Today, it's HashKey Capital and AMBR joining forces, marching into uncharted financial territories. This partnership is more than just a signature on a piece of paper; it's a declaration—a commitment...
Continue Reading
A New Player in Dallas-Fort Worth SecureSpace Self Storage has stormed into the Dallas-Fort Worth area, ushering in a sizeable expansion with four brand-new locations. This move is big news for the self-storage operator, marking its very first foray into the Texan market and boosting its nationwide presence past that century mark – 101 stores and counting. Call it a...
Continue Reading
Cerbo Enhances Telehealth With AI Scribe Expansion The digital healthcare playground looks like it's getting a nudge toward efficiency with Cerbo's latest move. Just when you thought telehealth couldn't get much sharper, these folks have drawn a line in the sand with their AI Scribe, which now makes its presence felt in virtual visits. No more juggling a dozen screens...
Continue Reading
China's Health Strategy in Poverty Reduction Here's a story that's got global implications tucked into its every corner: China, a country that's been trying to mesh healthcare with poverty reduction, has caught the eye of international observers. This insight was splashed across the latest Lancet Commission report, showcased at Tsinghua University on October 29. It seems...
Continue Reading
Top 5 Most Recently Viewed Articles
Lightbridge Corporation Achieves Milestone in Nuclear Fuel Development In a significant advancement for nuclear energy, Lightbridge Corporation (Nasdaq: LTBR) has successfully fabricated coupon samples using an enriched uranium-zirconium alloy. This achievement marks a crucial step in the creation of their next-generation Lightbridge Fuel™ product aimed at improving the...
Continue Reading
Basilea Announces Major Sales Achievement for Cresemba® Basilea Pharmaceutica Ltd, a key player in the biopharmaceutical arena, recently made headlines with a significant announcement regarding its antifungal medication Cresemba® (isavuconazole). The company reported outstanding sales performance driven by its license partner, Pfizer Inc., across Europe, which has led...
Continue Reading
Xiaomi's Historic Profit from Electric Vehicle Sales Chinese technology giant Xiaomi Corp (OTC: XIACY) has recently made waves by reporting its first-ever profit from its electric vehicle (EV) division. This significant milestone was part of its quarterly financial results, which revealed an astounding 80.9% increase in overall profits, reaching RMB11.3 billion...
Continue Reading
A Closer Look at the Digimarc Corporation Lawsuit The DJS Law Group is currently involved in a class action lawsuit against Digimarc Corporation (NASDAQ: DMRC) that has caught the attention of investors. This legal issue highlights significant concerns regarding the company's practices and transparency, which have implications for shareholders. What the Lawsuit Entails...
Continue Reading
Infragistics Welcomes Jason Beres as First Chief Operating Officer Infragistics, a pioneer in UX/UI solutions and data-driven tools for enterprise applications, has announced the appointment of Jason Beres as its inaugural Chief Operating Officer (COO). Previously serving as the Senior Vice President of Developer Tools, Beres will take the reins to steer the company's AI...
Continue Reading